MADELINE VANDECAPPELLE: Open Payments
NPI 1649839911 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 13 payments from 6 companies in 2025. Trend: 2023 $179 · 2024 $676 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $101 |
| ABBVIE INC. | 5 | $95 |
| Exact Sciences Corporation | 3 | $53 |
| Novo Nordisk Inc | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $15 |
Products named: Yeztugo, VRAYLAR, Cologuard Collection Kit, QULIPTA, Qelbree, FREESTYLE LIBRE 3, Ozempic.
Industry payments across IN — which companies pay providers there.
